WO2000006143A1
(en)
*
|
1998-07-27 |
2000-02-10 |
Texas Pharmaceuticals, Inc. |
Chemically induced intracellular hyperthermia
|
EP1140069A1
(en)
|
1998-12-24 |
2001-10-10 |
Novation Pharmaceuticals Inc. |
COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
|
US6811788B2
(en)
*
|
2000-01-19 |
2004-11-02 |
Baofa Yu |
Combinations and methods for treating neoplasms
|
US7927612B2
(en)
|
2000-01-19 |
2011-04-19 |
Baofa Yu |
Combinations and methods for treating neoplasms
|
GB0103809D0
(en)
|
2001-02-16 |
2001-04-04 |
Univ Dundee |
Methods
|
WO2003041643A2
(en)
|
2001-11-09 |
2003-05-22 |
Conforma Therapeutics Corporation |
Hsp90-inhibiting zearalanol compounds and methods of producing and using same
|
JPWO2003103658A1
(ja)
*
|
2002-06-05 |
2005-10-06 |
株式会社医薬分子設計研究所 |
免疫関連プロテインキナーゼ阻害剤
|
WO2004032864A2
(en)
*
|
2002-10-07 |
2004-04-22 |
Radiorx, Inc. |
X-nitro compounds, pharmaceutical compositions thereof and uses therof
|
EP1575575B1
(en)
*
|
2002-11-08 |
2010-05-19 |
High Point Pharmaceuticals, LLC |
Safe chemical uncouplers for the treatment of obesity
|
RU2006116421A
(ru)
|
2003-11-25 |
2008-01-10 |
Ново Нордиск А/С (DK) |
Анилиды салициловой кислоты
|
US20050250709A1
(en)
*
|
2003-12-19 |
2005-11-10 |
Bionaut Pharmaceuticals |
Anti-neoplastic agents, combination therapies and related methods
|
ES2809302T3
(es)
|
2004-01-22 |
2021-03-03 |
Univ Miami |
Formulaciones de coenzima Q10 para tratar tumores sólidos mediante administración intravenosa
|
JP2007536344A
(ja)
*
|
2004-05-04 |
2007-12-13 |
ノボ ノルディスク アクティーゼルスカブ |
新規のインドール誘導体
|
US8222253B2
(en)
*
|
2004-10-23 |
2012-07-17 |
Case Western Reserve University |
Peptide and small molecule agonists of EphA and their uses
|
WO2006053680A1
(en)
*
|
2004-11-19 |
2006-05-26 |
Nowicky Wassili |
Ex vivo cancer diagnostic method
|
WO2006053649A1
(en)
*
|
2004-11-19 |
2006-05-26 |
Nowicky Wassili |
Method for the detection of cancer
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
US20070135380A1
(en)
|
2005-08-12 |
2007-06-14 |
Radiorx, Inc. |
O-nitro compounds, pharmaceutical compositions thereof and uses thereof
|
WO2007087313A2
(en)
*
|
2006-01-25 |
2007-08-02 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for determining metabolic rate using temperature sensitive magnetic resonance imaging
|
CN101138634A
(zh)
|
2006-09-07 |
2008-03-12 |
于保法 |
用于治疗肿瘤的组合物
|
AU2009233785B2
(en)
|
2008-04-11 |
2015-08-20 |
Berg Llc |
Methods and use of inducing apoptosis in cancer cells
|
GB0806794D0
(en)
*
|
2008-04-15 |
2008-05-14 |
Ludwig Inst Cancer Res |
Therapeutic compounds
|
US9795693B2
(en)
*
|
2008-09-10 |
2017-10-24 |
Koninklijke Philips N.V. |
Drug carrier providing MRI contrast enhancement
|
KR20180056816A
(ko)
|
2009-05-11 |
2018-05-29 |
베르그 엘엘씨 |
환경대사적 전환인자(조효소 q10)를 사용한 질환의 치료 방법
|
JP2013518618A
(ja)
*
|
2010-02-01 |
2013-05-23 |
ザ・ホスピタル・フォー・シック・チルドレン |
再狭窄を治療および予防するための遠隔虚血コンディショニング
|
US8471041B2
(en)
|
2010-02-09 |
2013-06-25 |
Alliant Techsystems Inc. |
Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
|
SG10201502031XA
(en)
|
2010-03-31 |
2015-05-28 |
Hospital For Sick Children |
Use of remote ischemic conditioning to improve outcome after myocardial infarction
|
KR20130040878A
(ko)
|
2010-04-08 |
2013-04-24 |
더 호스피탈 포 식 칠드런 |
외상성 손상을 위한 원격 허혈 처치의 사용
|
US8560365B2
(en)
|
2010-06-08 |
2013-10-15 |
International Business Machines Corporation |
Probabilistic optimization of resource discovery, reservation and assignment
|
US9646271B2
(en)
|
2010-08-06 |
2017-05-09 |
International Business Machines Corporation |
Generating candidate inclusion/exclusion cohorts for a multiply constrained group
|
US8968197B2
(en)
*
|
2010-09-03 |
2015-03-03 |
International Business Machines Corporation |
Directing a user to a medical resource
|
US9292577B2
(en)
|
2010-09-17 |
2016-03-22 |
International Business Machines Corporation |
User accessibility to data analytics
|
ITMI20102043A1
(it)
*
|
2010-11-03 |
2012-05-04 |
Alberto Gramaglia |
Kit per l attivazione localizzata di elevate concentrazioni di un farmaco e suo procedimento
|
EP2640373A4
(en)
*
|
2010-11-16 |
2014-04-23 |
Univ New Jersey Med |
TREATMENT OF TYPE II DIABETES AND DIABETES ASSOCIATED DISEASES WITH SAFE CHEMICAL MITOCHONDRIENE COPPERS
|
US20130261368A1
(en)
*
|
2011-09-23 |
2013-10-03 |
Alan N. Schwartz |
Non-invasive and minimally invasive and tightly targeted minimally invasive therapy methods and devices for parathyroid treatment
|
US20120190979A1
(en)
|
2011-01-24 |
2012-07-26 |
Actium BioSystems, LLC |
System for automatically amending energy field characteristics in the application of an energy field to a living organism for treatment of invasive agents
|
US8968171B2
(en)
|
2011-01-24 |
2015-03-03 |
Endomagnetics Limited |
System for correlating energy field characteristics with target particle characteristics in the application of an energy field to a living organism for imaging and treatment of invasive agents
|
US20120190911A1
(en)
*
|
2011-01-24 |
2012-07-26 |
Actium BioSystems, LLC |
Low temperature hyperthermia system for therapeutic treatment of invasive agents
|
US8757166B2
(en)
|
2011-01-24 |
2014-06-24 |
Actium BioSystems, LLC |
System for defining energy field characteristics to illuminate nano-particles used to treat invasive agents
|
US20120269867A1
(en)
|
2011-04-04 |
2012-10-25 |
Jimenez Joaquin J |
Methods of treating central nervous system tumors
|
EP2527440A1
(en)
*
|
2011-05-27 |
2012-11-28 |
Institut Curie |
Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
|
AU2012300534B2
(en)
|
2011-08-26 |
2016-12-01 |
Endomagnetics Ltd |
Apparatus for the generation of an energy field for the treatment of cancer in body cavities and parts that are cavity-like
|
US8664247B2
(en)
|
2011-08-26 |
2014-03-04 |
Radiorx, Inc. |
Acyclic organonitro compounds for use in treating cancer
|
WO2013052164A1
(en)
|
2011-10-07 |
2013-04-11 |
Radiorx, Inc. |
Organonitro thioether compounds and medical uses thereof
|
WO2013052803A2
(en)
|
2011-10-07 |
2013-04-11 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
US20140073907A1
(en)
|
2012-09-12 |
2014-03-13 |
Convergent Life Sciences, Inc. |
System and method for image guided medical procedures
|
JP2016512709A
(ja)
|
2013-03-15 |
2016-05-09 |
ザ・ホスピタル・フォー・シック・チルドレンThe Hospital For Sick Children |
遠隔虚血コンディショニングを用いてオートファジをモジュレートする方法
|
US10098779B2
(en)
|
2013-03-15 |
2018-10-16 |
The Hospital For Sick Children |
Treatment of erectile dysfunction using remote ischemic conditioning
|
CA2904162A1
(en)
|
2013-03-15 |
2014-12-18 |
The Hospital For Sick Children |
Methods relating to the use of remote ischemic conditioning
|
SG11201508272YA
(en)
|
2013-04-08 |
2015-11-27 |
Berg Llc |
Treatment of cancer using coenzyme q10 combination therapies
|
RU2542454C2
(ru)
*
|
2013-05-31 |
2015-02-20 |
ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ ОБРАЗОВАТЕЛЬНОЕ УЧРЕЖДЕНИЕ ВЫСШЕГО ПРОФЕССИОНАЛЬНОГО ОБРАЗОВАНИЯ "НИЖЕГОРОДСКАЯ ГОСУДАРСТВЕННАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РФ (ГБОУ ВПО "НижГМА" МИНЗДРАВА РОССИИ) |
Способ общей управляемой гипертермии
|
US10457629B2
(en)
|
2013-08-30 |
2019-10-29 |
Yale University |
Therapeutic DNP derivatives and methods using same
|
US10786466B2
(en)
*
|
2013-08-30 |
2020-09-29 |
Yale University |
2,4-dinitrophenol formulations and methods using same
|
SG10201907816RA
(en)
|
2013-09-04 |
2019-09-27 |
Berg Llc |
Methods of treatment of cancer by continuous infusion of coenzyme q10
|
US9950194B2
(en)
|
2014-09-09 |
2018-04-24 |
Mevion Medical Systems, Inc. |
Patient positioning system
|
US9459201B2
(en)
|
2014-09-29 |
2016-10-04 |
Zyomed Corp. |
Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing
|
CN107205971A
(zh)
|
2014-11-18 |
2017-09-26 |
罗格斯,新泽西州立大学 |
用于治疗代谢疾病和癌症的新的线粒体解偶联剂
|
EP3223810A1
(en)
|
2014-11-26 |
2017-10-04 |
Baofa Yu |
Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy
|
CN104974100A
(zh)
*
|
2015-07-07 |
2015-10-14 |
江苏省农业科学院 |
来源于抗生素溶杆菌oh13的吩嗪类化合物及其制备方法与应用
|
SI3325623T1
(sl)
|
2015-07-23 |
2019-11-29 |
Inst Curie |
Uporaba kombinacije molekule DBAIT in inhibitorjev PARP za zdravljenje raka
|
EA201890618A1
(ru)
|
2015-09-01 |
2018-10-31 |
Ферст Вэйв Байо, Инк. |
Способы и композиции для лечения состояний, ассоциированных с аномальными воспалительными ответами
|
US10342778B1
(en)
|
2015-10-20 |
2019-07-09 |
Epicentrx, Inc. |
Treatment of brain metastases using organonitro compound combination therapy
|
US9987270B1
(en)
|
2015-10-29 |
2018-06-05 |
Epicentrix, Inc. |
Treatment of gliomas using organonitro compound combination therapy
|
DE102015016801A1
(de)
*
|
2015-12-23 |
2017-06-29 |
Christian Windisch |
Chemotherapeutisches Verfahren zur Behandlung maliger Geschwülste durch "Entkopplung" der oxidativen Phosphorilierung ("Krebsatmung") in aerob glycolysierenden Zellen (Krebszellen)
|
EP3402480B1
(en)
|
2016-01-11 |
2021-03-24 |
EpicentRx, Inc. |
Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
|
US9554738B1
(en)
|
2016-03-30 |
2017-01-31 |
Zyomed Corp. |
Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
|
EP3458454B1
(en)
|
2016-05-18 |
2021-11-24 |
Rutgers, The State University of New Jersey |
2-hydroxy-n-(benzo[d]thiazol-2-yl)benzamide derivatives as mitochondrial uncouplers for the treatment of metabolic diseases and cancer
|
SG11201903312VA
(en)
|
2016-10-14 |
2019-05-30 |
Epicentrix Inc |
Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
|
KR102580606B1
(ko)
|
2016-11-17 |
2023-09-19 |
레트로토프 인코포레이티드 |
동위원소로 변형된 성분 및 이의 치료학적 용도
|
US20200138015A1
(en)
*
|
2017-04-04 |
2020-05-07 |
University Health Network |
Apparatus and Methods for Irradiating Organ Perfusates
|
US11744859B2
(en)
|
2017-07-07 |
2023-09-05 |
Epicentrx, Inc. |
Compositions and methods for parenteral administration of therapeutic agents
|
US11510901B2
(en)
|
2018-01-08 |
2022-11-29 |
Epicentrx, Inc. |
Methods and compositions utilizing RRx-001 combination therapy for radioprotection
|
WO2019217164A1
(en)
*
|
2018-05-09 |
2019-11-14 |
Reyoung Corporation |
Compositions and methods for treating cancer and other diseases
|
CN109340993B
(zh)
*
|
2018-09-17 |
2020-11-10 |
北京控制工程研究所 |
一种空调智能红外模块检测装置
|
CN111205196B
(zh)
*
|
2020-03-04 |
2021-04-02 |
中国科学院昆明植物研究所 |
一种苯酚类ab环结构化合物及其制备方法和应用
|
US10980756B1
(en)
|
2020-03-16 |
2021-04-20 |
First Wave Bio, Inc. |
Methods of treatment
|
CN111643670A
(zh)
*
|
2020-05-29 |
2020-09-11 |
新疆医科大学 |
能量双调控药物及其制备方法和应用
|
CA3219548A1
(en)
|
2021-05-20 |
2022-11-24 |
Rivus Pharmaceuticals, Inc. |
Methods of treating mitochondria-related disorders
|
WO2023014882A1
(en)
*
|
2021-08-04 |
2023-02-09 |
Mitochon Pharmaceuticals, Inc. |
2,4 dnp and prodrugs thereof for treatment of cancer
|
WO2023046941A1
(fr)
*
|
2021-09-27 |
2023-03-30 |
Universite Paris Cite |
Inhibiteurs de l'interaction entre les protéines kinases rock et pdk1
|
WO2023205625A2
(en)
*
|
2022-04-18 |
2023-10-26 |
Mitochon Pharmaceuticals, Inc. |
2,4 dnp and prodrugs thereof for treatment of pulmonary and autoimmune diseases
|